Compared to breast cancer cells with low bone metastatic activity, the expression of serine metabolic enzymes (including PHGDH, PSAT1 and PSPH) was increased in breast cancer cells with high bone metastatic activity (113). This evidence concerns the gene PSAT1 and breast carcinoma.